Propantheline Bromide: The Complete Guide for Pharmaceutical Manufacturers & Healthcare Professionals
Propantheline bromide—you might know it best by its iconic brand name Pro‑Banthine®.
Over the years, this drug has quietly done its job: calming down overactive guts, drying up sweat, and helping people regain control of their bladder.
But here is where things get interesting. Pro‑Banthine was discontinued in the United States several years ago, and the resulting market gap has created a rare opportunity for compounding pharmacies and specialty pharmaceutical manufacturers.
Today, we are seeing a huge resurgence of interest—not just in the finished tablet, but in the API (active pharmaceutical ingredient) itself.
In this guide, we will strip away the hype and give you the hard facts: what this drug is, how it works, the real-world side effects, dosing strategies, how it stacks up against alternatives like glycopyrrolate and hyoscyamine, and—most importantly for our industry—where and how to source high‑quality, GMP‑compliant Propantheline Bromide API.
Whether you are a procurement manager sourcing APIs, a compounding pharmacist seeking compliant materials, or a manufacturer developing a new formulation, consider this your technical playbook.
What is Propantheline Bromide?
Propantheline bromide is a synthetic quaternary ammonium anticholinergic agent—a mouthful of chemistry that basically means it is a lab‑made compound designed to block acetylcholine’s action in the body.
In plain English, it is a white to off‑white crystalline powder with a bitter taste, very soluble in water and chloroform, but practically insoluble in ether and acetone. Its molecular weight is 448.39 g/mol, and its melting point is 159‑161°C.
Propantheline bromide has a dual mechanism: it exerts a specific anticholinergic (antimuscarinic) effect at acetylcholine‑receptor sites and a direct musculotropic (smooth-muscle-relaxing) effect.
The dual action makes it particularly effective for reducing gastrointestinal motility, calming smooth‑muscle spasms in the gut and bladder, and drying up secretions.
For the compounding pharmacy or pharmaceutical manufacturer, the key takeaway is that Propantheline Bromide API is a well‑established, well‑understood molecule with decades of clinical use.
What are Propantheline Bromide Brand Names?
Propantheline bromide has been marketed under several brand names globally. The most famous is Pro‑Banthine®, originally developed by G.D. Searle & Co. and later marketed by Shire and others.
In the United States, the Pro‑Banthine brand has been discontinued.
However, generic versions of Propantheline Bromide have been approved by the FDA and are available through compounding pharmacies and specialty manufacturers.
Other global brand names and synonyms for Propantheline Bromide include:
Neometantyl
Neopepulsan
Corrigast
Ercorax
Ercotina
Ketaman
Kivatin
Pantas
Pantheline
Pervagal
Pro‑Banthine (the most well‑known brand)
This drug has been approved in 13 New Drug Applications (NDAs), with 12 applicants, including major generics players such as Mylan, Sandoz, Hikma, Impax Labs, Par Pharmaceutical, Watson Labs, and others.
Key Regulatory Status for the U.S. Market
All brand‑name and generic tablet formulations in the U.S. have been discontinued. It means that if a patient needs this medication today, it must be compounded using a compliant API. That shift has made Propantheline Bromide API a critical material for the 503A and 503B compounding pharmacy sector.
What is Propantheline Bromide Used For?
Propantheline bromide is a versatile drug with several FDA‑approved and off‑label uses.
Approved & Widely Accepted Indications
1. Peptic Ulcer Disease (Gastric and Duodenal)
Propantheline is indicated as adjunctive therapy in the treatment of peptic ulcers. It reduces gastric acid secretion and inhibits gastrointestinal motility, relieving the symptoms of hyperacidity.
2. Irritable Bowel Syndrome (IBS)
It is indicated for the symptomatic treatment of irritable bowel syndrome, including irritable colon, spastic colon, mucous colitis, acute enterocolitis, and nervous diarrhea. Propantheline reduces abdominal cramping and the sensation of urgency that makes IBS so debilitating.
3. Gastritis
The drug relieves the uncomfortable symptoms of gastritis: pain, bloating, and nausea.
4. Hyperhidrosis (Excessive Sweating)
Propantheline reduces sweating by blocking the nerve signals that trigger sweat gland activity.
It is used for both focal and generalized hyperhidrosis. Studies show that systemic anticholinergics such as propantheline, oxybutynin, and glycopyrrolate are highly effective in treating various forms of hyperhidrosis, including palmoplantar and generalized hyperhidrosis.
Oxybutynin has been reported to improve symptoms in 60‑97% of patients, and propantheline shows similar efficacy in this class of drugs.
5. Enuresis (Involuntary Urination / Bedwetting)
Propantheline helps reduce involuntary bladder contractions by blocking parasympathetic input to the detrusor muscle.
6. Renal Colic
The antispasmodic effect on ureteral smooth muscle makes propantheline useful for treating renal colic and facilitating the passage of kidney stones.
7. Additional Off‑Label Uses
Neurocardiogenic syncope (vasovagal fainting): a clinical trial of 16 patients found propantheline bromide to be highly effective in preventing syncope, with 13 of 16 patients (81%) having no inducible presyncope on repeat tilt‑table testing after treatment.
Urinary incontinence (detrusor overactivity): the usual adult oral dose is 15‑30 mg every 4‑6 hours, although higher doses are often necessary.
As adjunctive therapy for ulcerative colitis, diverticulitis, cholecystitis, and pancreatitis.
How does Propantheline Bromide Work? (Mechanism of Action)
This is where the drug truly shines.
Propantheline bromide works through a dual‑action mechanism, making it more effective than many simpler antispasmodics.
Mechanism One: Competitive Muscarinic Receptor Antagonism
Propantheline competitively antagonizes acetylcholine at muscarinic receptors located on smooth muscle cells and exocrine gland cells throughout the body.
Normally, acetylcholine binds to these receptors, causing muscle contraction. Propantheline interferes by blocking that signal, causing smooth muscle relaxation.
This antagonism reduces:
Gastrointestinal tone and motility
Gastric acid secretion
Salivary, bronchial, pancreatic, and sweat gland secretions
Mechanism Two: Direct Musculotropic Effect
Beyond its receptor‑blocking action, propantheline also exerts a direct relaxing effect on smooth muscle itself. It means the drug calms muscle spasms in the gut and bladder, even if acetylcholine levels are already low.
The Quaternary Ammonium Advantage
Propantheline is a quaternary ammonium compound, which means it carries a permanent positive charge. That charge has major clinical implications:
Poor absorption – only about 1‑10% of an oral dose reaches systemic circulation unchanged.
Does NOT readily cross the blood‑brain barrier – central nervous system side effects (confusion, drowsiness) are far less common than with tertiary amines like atropine.
Action is primarily peripheral – the drug works where you want it (the gut, the bladder, the sweat glands) without fogging the patient’s brain.
What happens to the drug in the body?
Propantheline bromide is extensively metabolized in humans, primarily by hydrolysis to two inactive metabolites: xanthene‑9‑carboxylic acid and (2‑hydroxyethyl) diisopropylmethylammonium bromide.
Approximately 70% of a dose is excreted in the urine, mostly as metabolites, while only about 3% is excreted unchanged.
What are Propantheline Bromide Side Effects?
No drug is perfect, and propantheline has a predictable side‑effect profile that stems directly from its mechanism of action: anticholinergic effects.
Most Common Side Effects (Dose‑Related and Usually Reversible)
| Body System | Side Effect | Cause |
|---|---|---|
| Mouth & Throat | Dry mouth, thirst, difficulty swallowing | Reduced salivary secretion |
| Eyes | Blurred vision, dilated pupils (mydriasis), sensitivity to light | Paralysis of the ciliary muscle, pupil dilation |
| Cardiovascular | Tachycardia (increased heart rate), palpitations, flushing | Blockade of cardiac muscarinic receptors |
| Gastrointestinal | Constipation, nausea, vomiting, loss of taste | Reduced GI motility |
| Genitourinary | Urinary hesitancy, urinary retention, impotence | Detrusor muscle relaxation |
| Skin | Dry skin, decreased sweating | Blocked sweat gland innervation |
| Nervous System | Headache, dizziness, nervousness, insomnia, weakness | Mild CNS effects (despite limited BBB penetration) |
A 2026 review noted that across all anticholinergics used for hyperhidrosis, the most common adverse effects were xerostomia (dry mouth), constipation, and visual disturbances, with quaternary ammonium compounds (such as propantheline) showing fewer CNS side effects than tertiary amines.
Serious Adverse Effects (Rare but Important)
Heat prostration (fever and heat stroke) – because the drug reduces sweating, patients can overheat in hot environments. This is a real risk in elderly patients.
Diarrhea – counterintuitively, diarrhea can be an early symptom of incomplete intestinal obstruction in patients with ileostomy or colostomy, in which case propantheline would be inappropriate and possibly harmful.
Curare‑like action with overdose – neuromuscular blockade leading to muscular weakness and possible paralysis.
Hypersensitivity reactions – anaphylaxis, urticaria, and other dermal manifestations.
Overdose Symptoms
With overdose, patients may experience intensification of usual adverse effects (nausea, vomiting), CNS disturbances (excitement, delirium, hallucinations), hyperthermia, respiratory depression, and even coma. In severe cases, IV physostigmine 0.5‑2 mg may be administered.
Contraindications (When NOT to Use)
Absolute contraindications include:
Glaucoma (especially narrow‑angle)
Obstructive disease of the GI tract (pyloroduodenal stenosis, achalasia, paralytic ileus)
Obstructive uropathy (bladder‑neck obstruction due to prostatic hypertrophy)
Intestinal atony in elderly or debilitated patients
Severe ulcerative colitis or toxic megacolon
Unstable cardiovascular adjustment in acute hemorrhage
Myasthenia gravis
What Are Furosemide Side Effects?
Furosemide side effects aren’t just a list to be recited; they’re lived experiences that can degrade quality of life if not managed.
Let’s break them down by urgency and frequency.
Fluid and Electrolyte Imbalances:
Hypokalemia (low potassium) – cramps, palpitations, ECG changes.
Hypomagnesemia can worsen hypokalemia and cause arrhythmias.
Hyponatremia – particularly dangerous if rapid onset, leading to confusion, seizures.
Dehydration – dizziness, orthostatic hypotension, falls in elderly patients.
Metabolic alkalosis – due to chloride loss and volume contraction; often asymptomatic until severe.
Ototoxicity:
This one keeps me up at night. Furosemide, especially at high IV doses, can cause reversible or permanent sensorineural hearing loss.
It’s linked to peak serum concentrations; avoid rapid IV pushes and be extremely cautious in patients with renal failure or those on other ototoxic drugs like aminoglycosides.
Tinnitus and vertigo are the warning signs. If a patient tells you their ears are ringing, stop and reevaluate.
Metabolic Effects:
Hyperuricemia – furosemide competes with uric acid for tubular secretion, potentially triggering gout attacks.
Hyperglycemia – loop diuretics can impair glucose tolerance, probably through hypokalemia-induced reduction in insulin secretion.
Dyslipidemia – long-term use may increase LDL and triglyceride levels, though the clinical significance is debated.
Renal Effects:
Pre-renal azotemia from overdiuresis can be mistaken for worsening renal failure. This is why daily weights and orthostatic vitals are essential.
Interstitial nephritis – a rare but serious allergic reaction.
Other:
Sulfonamide allergy cross-reactivity – if a patient has a true sulfa allergy, furosemide can cause rash, urticaria, or even anaphylaxis. Ethacrynic acid is the alternative loop diuretic.
Photosensitivity, bullous eruptions, and pancreatitis (rare).
The proactive strategy is to monitor, monitor, monitor—electrolytes, renal function, volume status.
I’ve seen clinicians blame a patient’s fall on “old age” when it was really furosemide-induced orthostasis.
Let’s not be those practitioners.
Propantheline Bromide Dosage and Administration
Getting the dose right is critical—too little and the drug does nothing; too much and the patient is miserable with dry mouth and blurred vision.
Standard Adult Dosage (Tablets / Oral)
The most common starting dose for a peptic ulcer is:
15 mg three times daily, 30 minutes before meals
Plus 30 mg at bedtime
Total daily dose: 75 mg
The maximum daily dose should not exceed 120 mg.
The dosing strategy follows a simple titration rule: increase the dose gradually until the patient experiences dry mouth, then back off slightly. That “dry mouth threshold” is the sweet spot.
For other indications (IBS, hyperhidrosis, enuresis, renal colic):
15‑30 mg four times daily
Adjust based on clinical response and tolerability
Important Administration Notes
Take on an empty stomach, 30 minutes before meals – food significantly decreases absorption.
Patients should swallow tablets whole with a glass of water.
Avoid alcohol while taking propantheline, as it may worsen drowsiness or dizziness.
Be cautious with hot environments – the patient’s reduced sweating makes them vulnerable to overheating.
Pediatric Dosing
Propantheline is rarely used in children and should be administered only under a physician’s supervision. Dosing is based on body weight and clinical response.
Onset & Duration of Action
Onset of effect: within 1 hour of oral administration.
Duration of effect: up to 6 hours.
Time to peak plasma concentration: about 1 hour.
What if a Dose is Missed?
Take the missed dose as soon as you remember, but skip it if it is almost time for your next dose. Never double up.
Propantheline Bromide vs. its Alternatives
If you are a pharmacist, manufacturer, or formulary manager, you are probably thinking: “Why choose propantheline over the dozens of other anticholinergics out there?”
Here is the honest comparison.
| Drug Name | Class | BBB Penetration | Duration | Key Advantages | Key Disadvantages |
|---|---|---|---|---|---|
| Propantheline | Quaternary ammonium | Very low | 4‑6 hours | Reduced CNS side effects; dual mechanism (musculotropic + antimuscarinic); excellent GI selectivity | Low oral bioavailability (1‑10%) requires higher oral doses |
| Atropine | Tertiary amine (alkaloid) | High | ~4 hours | Potent; inexpensive | Significant CNS effects; tachycardia; well‑absorbed from the GI tract |
| Hyoscyamine | Tertiary amine | Moderate | 4‑6 hours | Approved for IBS in the US; sublingual rapid‑acting form | More CNS effects than quaternaries; drowsiness is common |
| Glycopyrrolate | Quaternary ammonium | Very low | 6‑8 hours | Longer duration than propantheline; excellent for hyperhidrosis; fewer CNS effects | More expensive; less GI‑selective than propantheline |
| Dicyclomine | Tertiary amine | Moderate | 4‑6 hours | Approved for IBS in the US; inexpensive | CNS effects (drowsiness, dizziness) are significant |
Comparative Efficacy Data
Propantheline is the isopropyl analog of methantheline and has up to five times the antimuscarinic activity, a longer duration of action, and a smaller side‑effect profile.
One comparative study found that no available oral drug has a direct in vitro antimuscarinic binding potential closer to that of atropine than that of propantheline bromide.
A clinical trial treating neurocardiogenic syncope found propantheline bromide highly effective in preventing syncope, with 81% of patients showing no inducible presyncope on repeat tilt‑table testing after treatment.
Bottom Line for Formulators and Clinicians
Choose propantheline if:
You want a GI‑selective anticholinergic with minimal CNS side effects.
You are treating IBS, gastritis, or a peptic ulcer.
You are willing to titrate the dose based on the dry‑mouth threshold.
Choose alternatives if:
You need a longer duration of action (e.g., glycopyrrolate once daily).
The patient is intolerant of propantheline.
Cost and availability are major concerns (propantheline API is now a specialty item).
Propantheline Bromide Precautions and Drug Interactions
Special Populations – Use with Caution
Propantheline should be used with caution in the following populations:
Elderly patients – increased risk of constipation, urinary retention, mental confusion, and heat stroke.
Patients with cardiovascular disease – coronary artery disease, CHF, hypertension, or acute MI (tachycardia may worsen these conditions).
Patients with hiatal hernia associated with reflux oesophagitis – anticholinergics may aggravate reflux.
Patients with ulcerative colitis – large doses may suppress intestinal motility and precipitate paralytic ileus or toxic megacolon.
Patients with hepatic or renal impairment – reduced drug clearance increases the risk of adverse effects.
In patients with hyperthyroidism, tachycardia may be exacerbated.
Pregnant or breastfeeding women – avoid unless the potential benefit justifies the potential risk to the fetus/infant.
Drug‑Drug Interactions
| Interacting Drug | Mechanism / Effect |
|---|---|
| Digoxin (slow‑dissolving tablets) | Propantheline increases serum digoxin levels by delaying gastric emptying |
| Paracetamol (acetaminophen) | Reduced and delayed absorption |
| Ketoconazole | Reduced absorption |
| Levodopa | Reduced absorption |
| Nitrofurantoin | Enhanced absorption |
| Other anticholinergics | Additive effects – excessive muscarinic blockade |
| Amantadine, antihistamines, phenothiazines | Additive anticholinergic effects |
Warnings for Compounding Pharmacies
When preparing extemporaneous formulations of Propantheline Bromide, pay close attention to excipient selection.
The drug is hygroscopic at relative humidities above 50% and deliquescent above about 90%.
Ensure that your compounding environment is properly humidity‑controlled and that final dosage forms are stored in tightly sealed, moisture‑resistant containers.
Compounding Guidelines for Propantheline Bromide
For 503A and 503B compounding pharmacies, propantheline bromide presents both an opportunity and a challenge.
With all commercial tablet formulations discontinued in the U.S., compounding is the only route for patients who need this medication.
USP Compendial Standards
Propantheline Bromide API for compounding must comply with the USP Propantheline Bromide monograph, where applicable.
The USP monograph requires that the API contains not less than 98.0% and not more than 102.0% of C₂₃H₃₀BrNO₃, calculated on a dried basis.
Key USP specifications include:
Loss on drying: not more than 0.5%
Residue on ignition: not more than 0.1%
Identification: by IR absorption and thin‑layer chromatography
Bromide content: titrated with 0.1 N silver nitrate
Sourcing Compliant API
The most critical step is to source the API from a cGMP-compliant facility. It is non‑negotiable for 503A compounding (under sections 503A and 503B of the FD&C Act). Acceptable sources include:
FDA‑registered manufacturers with an active Drug Master File (DMF)
FDA‑registered repackagers that handle only FDA‑registered API
Domestic wholesalers with thorough supplier qualification processes
Quality Documentation Checklist
Every shipment of Propantheline Bromide API for compounding should include:
Lot‑specific Certificate of Analysis (CoA) with assay (98.0‑102.0%), impurity profile, residual solvents, heavy metals, and water content
Safety Data Sheet (SDS) compliant with GHS
Certificate of Origin, where required
Stability summary or access to the manufacturer’s stability data
DMF letter of authorization for regulatory reference
Extemporaneous Formulation Considerations
Propantheline bromide is very soluble in water and alcohol, which simplifies extemporaneous liquid formulation. For oral solutions:
Use purified water or a simple syrup vehicle
The drug is heat‑stable up to its melting point, but avoid prolonged heating
Protect from light (the xanthene moiety is light‑sensitive)
Store at 2‑8°C (refrigerated) in tightly closed containers
Use within a short beyond‑use date based on stability data (generally ≤14 days refrigerated for aqueous solutions unless stability studies support longer)
USP Propantheline Bromide Tablets Monograph
If you are compounding capsules or tablets, note that the USP monograph for Propantheline Bromide Tablets includes a dissolution test requirement: not less than 75% (Q) of the labeled amount of C₂₃H₃₀BrNO₃ is dissolved in 45 minutes. That is a good internal quality target for your compounded batches.
Reference Standards for Quality Control
For method development and QC testing, USP offers Propantheline Bromide USP Reference Standard for assay and impurity identification, as well as Propantheline Bromide USP Related Compound A for impurity profiling. Both are essential for any compounding pharmacy performing in‑house potency testing.
Prohibited Sources
The FDA explicitly warns compounders not to use APIs labeled “for research use only,” “not for human use,” or “for laboratory use only.” Regardless of how pure they appear on paper, those are not compliant for human compounding.
How long does Propantheline Bromide take to work?
Pharmacokinetics matter when you are deciding between drug A and drug B.
Propantheline bromide is rapidly absorbed but poorly bioavailable.
Absorption half‑life: 8‑30 minutes
Time to peak plasma concentration: within 1 to 3 hours of oral dosing
Onset of antimuscarinic effect: within 1 hour of oral administration
Duration of effect: persists for up to 6 hours
Elimination half‑life of the intact drug: approximately 1.6 hours
Terminal half‑life of total radioactivity (parent + metabolites): approximately 9.2 hours
What does this mean for your patients?
Within about 1 hour of taking the first dose, the patient should notice a reduction in gastrointestinal cramping, decreased urgency, or reduced sweating.
The effect will last about 4‑6 hours, after which a second dose is usually needed.
Because the drug is cleared relatively quickly (its terminal half‑life is short), side effects such as dry mouth and blurred vision are generally dose‑dependent and reversible, usually resolving within hours after the last dose.
Comparison with Other Anticholinergics
| Drug | Time to Peak | Duration | Half‑Life |
|---|---|---|---|
| Propantheline | 1‑3 hours | 4‑6 hours | ~1.6 hours (drug) / 9.2 h (total radio) |
| Glycopyrrolate | 2‑3 hours | 6‑8 hours | ~3 hours |
| Hyoscyamine | 1‑2 hours | 4‑6 hours | ~3.5 hours |
| Atropine | 1‑2 hours | 4‑6 hours | ~4 hours |
Food Effect
Food substantially decreases the extent of absorption of propantheline bromide. That is why the drug must be taken 30 minutes before meals or on an empty stomach.
Low Oral Bioavailability – A Feature, Not a Bug
Only about 1‑10% of an oral dose reaches systemic circulation unchanged.
It sounds terrible from a pharmacokinetic perspective, but it is precisely why the drug causes so few CNS side effects.
The drug acts locally in the gut and is metabolized before it can fog up the brain. It is a classic gut‑selective design.
Global Sourcing Tips for Propantheline Bromide API
This section is written specifically for our industry audience: procurement managers, CMOs, CROs, R&D directors, and compounding pharmacy owners.
The market for Propantheline Bromide API is niche, concentrated, and undergoing significant change.
Here is what you need to know to source successfully.
How to Choose the Right Supplier
When evaluating a Propantheline Bromide API supplier, demand these five deliverables:
Current GMP Certificate – from a recognized regulatory authority (FDA, EMA, PMDA, TGA).
Active Drug Master File (DMF) – Type II on file with the FDA in “Active” status.
Batch‑specific Certificate of Analysis (CoA) – assay 98.0‑102.0% on a dried basis, impurity profile, heavy metals, residual solvents.
Stability Data – at least 24 months of long‑term and accelerated stability studies under ICH conditions.
Supply Chain Transparency – full traceability from synthesis to final container, with clear lot numbers and expiry dates on each container.
Red Flags to Avoid
Suppliers that refuse to share their DMF number – walk away.
Suppliers whose CoA lacks lot numbers, expiry dates, or stability data – those are not real CoAs.
Suppliers claiming “USP grade” but cannot produce an FDA establishment registration – USP grade means nothing without cGMP compliance.
Sourcing from unregistered repackagers – repackagers must also be FDA‑registered and subject to inspection.
For Compounding Pharmacies Specifically
503A and 503B compounders must source Propantheline Bromide API from FDA‑registered facilities. Period.
When you place an order, ask for:
The manufacturer’s FDA establishment registration number
The DMF number and a letter of authorization, if needed
A lot‑specific CoA that explicitly states the material complies with the USP Propantheline Bromide monograph
Do not accept excuses. The FDA inspectors will not accept them either.
Conclusion
Propantheline Bromide is a classic drug that has stood the test of time. It is not flashy. It does not have billion‑dollar blockbuster sales.
But for patients suffering from IBS cramps, peptic ulcer pain, bladder overactivity, or the social misery of hyperhidrosis, this drug can be life‑changing.
From a manufacturing and compounding perspective, the discontinuation of Pro‑Banthine in the U.S. has turned a routine generic into a specialty compounded product.
That shift has opened up a stable, recurring demand for high‑quality, GMP‑compliant Propantheline Bromide API.
If you are sourcing this API, remember the non‑negotiable elements: FDA‑registered manufacturer, active DMF, 98%+ purity, and complete documentation. Do not cut corners. The patients who rely on this drug deserve better.
And if you are a clinician, keep this tool in your back pocket. When your patient fails on hyoscyamine or cannot tolerate the CNS effects of dicyclomine, propantheline’s gut‑selective, low‑CNS‑side‑effect profile might be exactly what they need.
Key Takeaways
Propantheline Bromide (Pro‑Banthine®) is a dual‑action anticholinergic used for IBS, peptic ulcer, gastritis, hyperhidrosis, and bladder disorders.
It is a quaternary ammonium compound that does not cross the blood‑brain barrier, resulting in fewer CNS side effects than tertiary amines like atropine or hyoscyamine.
The drug is discontinued in the U.S., making it a compounding‑only product in the American market.
Standard adult dosing: 15‑30 mg four times daily, taken 30 minutes before meals, titrated to the “dry mouth” threshold.
Propantheline is generally safe, but watch for dry mouth, blurred vision, tachycardia, constipation, urinary retention, and heat‑related illnesses in susceptible patients.
The API is a specialty niche market, with reliable sources concentrated in China, Europe, and North America.
Disclaimer:
This content is for informational purposes only and is intended for business-to-business communication within the pharmaceutical industry. It is not intended as medical advice. The manufacture, import, and use of API must comply with all applicable laws and regulations in the relevant country or region.
This blog post is informational only and does not constitute medical advice.
Always consult a healthcare professional before starting any new medication or treatment.
